UPDATE ON SFO ENQUIRY
31 March 2006 - 6:04PM
UK Regulatory
RNS Number:7356A
Goldshield Group PLC
31 March 2006
Goldshield Group PLC
UPDATE ON SFO ENQUIRY
In two separate letters from the Serious Fraud Office (SFO) dated 30 March 2006,
two of the executive directors of Goldshield Group Plc ('Goldshield') - Ajit
Patel and Kirti Patel - were notified that they will be charged on the 7th April
in relation to their alleged involvement in a conspiracy to defraud the
Secretary of State for Health and others in relation to warfarin and Marevan.
As of today no such notification of any charges against Goldshield has been
received.
Goldshield and both directors continue to maintain that they did not act in a
way that was unlawful or improper.
Ajit Patel and Kirti Patel are continuing in their executive positions with the
full support of the Board of Directors of Goldshield.
Goldshield has given its full co-operation to the SFO investigation and, whilst
it is disappointed by this development, it has prepared its business for the
challenges ahead and the management will continue with the successful
implementation of its business strategy.
-ends-
Date: 31 March 2006
For further information please contact:
Goldshield Group plc City Profile
Ajit Patel, Chief Executive Jonathan Gillen
Rakesh Patel, Finance Director Tel: 020-7448-3244
Tel: 020-8649-8500 Mob: 07970-475659
Web: www.goldshieldplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKDFDSAKEEE
Goldshield (LSE:GSD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Goldshield (LSE:GSD)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Goldshield Grp (London Stock Exchange): 0 recent articles
More Goldshield Grp Plc News Articles